Education
About Us
Working with TipRanks
Follow Us
Achieve Life Sciences Inc (ACHV)
NASDAQ:ACHV
Earnings Data
Report Date
Mar 12, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.27Last Year’s EPS
-0.36Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant regulatory achievements and strategic advancements, particularly in gaining an expedited review for vaping cessation. However, funding needs for further clinical trials and challenges in aligning commercial strategies for two different market entries pose potential risks.Company Guidance
FDA Priority Voucher for Vaping Indication
Achieve Life Sciences received a Commissioner's National Priority Voucher from the FDA for cytisinicline in vaping cessation, allowing for expedited NDA review and potential early market entry.
Regulatory Milestones Achieved
FDA accepted the NDA for cytisinicline for smoking cessation with a PDUFA date set for June 20, 2026. A 120-day safety review was also submitted on time.
Positive Outcomes from COPD Studies
Smokers with COPD had higher quit rates on cytisinicline compared to placebo in Phase III trials, indicating cytisinicline's potential to aid a difficult-to-treat population.
Commercial Strategy and AI Integration
Achieve is integrating AI-driven tools for precision targeting in its commercialization strategy, enhancing engagement and optimizing resource allocation.
Strong Financial Position
As of September 30, 2025, Achieve had $48.1 million in cash, cash equivalents, and marketable securities, with a cash runway extending into the second half of 2026.
ACHV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ACHV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $4.93 | $4.74 | -3.85% |
Aug 07, 2025 | $2.64 | $2.64 | 0.00% |
May 13, 2025 | $2.48 | $2.65 | +6.85% |
Mar 11, 2025 | $3.06 | $2.92 | -4.58% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Achieve Life Sciences Inc (ACHV) report earnings?
Achieve Life Sciences Inc (ACHV) is schdueled to report earning on Mar 12, 2026, After Close (Confirmed).
What is Achieve Life Sciences Inc (ACHV) earnings time?
Achieve Life Sciences Inc (ACHV) earnings time is at Mar 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ACHV EPS forecast?
ACHV EPS forecast for the fiscal quarter 2025 (Q4) is -0.27.